Elligo Health Research’s Growth Supported by New Executive Leadership

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Why Custom Tin Containers Are Reshaping Medicine & Supplement Packaging

In an industry driven by both compliance and consumer...

Sarclisa by Sanofi has EC Approval to Treat Multiple Myeloma

In order to treat multiple myeloma in adults, Sarclisa...

US Levies 15% Tariff on EU for Pharmaceutical Products

The European Union is going to pay the US...

EU-US Trade Deal Taking Shape as Pharma Tariffs Materialize

Finally, the Trump administration’s much-animated tariffs on pharmaceutical imports...

Elligo Health Research, an integrated research organization, has added Dan Pucci, MBA, as vice president of strategic partnerships, and Michael A. Ibara, Pharm.D., as vice president of data sciences, to its executive leadership team.

Pucci will lead Elligo’s strategic partnerships and new practice development group. Through this group, and in partnership with Elligo’s network management group, Pucci will develop key business relationships that grow and nurture Elligo’s network of Research Ready sites. In this role, he will directly support Elligo’s effort to bring together health care data with community physicians and their patients.

Pucci has a decade of experience building commercial and research partnerships with life sciences and health care insights organizations. Prior to Elligo, he helped develop and grow the point-of-care content, and payer and life sciences business units at Allscripts Healthcare Solutions.

Ibara, who has a record of innovation in the pharmaceutical industry and more than two decades of experience bringing together health care data and digital technologies in regulatory environments, most recently served as head of digital health care for the Clinical Data Interchange Standards Consortium (CDISC).

In his new role, Ibara will support the data sciences team as they apply analytical and algorithmic techniques to clinical data, improving patient matching, trend identification and reporting of insights to patients, investigators and sponsors. Ibara will also lead data-driven research projects for Elligo’s clients and provide subject matter expertise across all aspects of pharmacovigilance.

“Elligo has seen a lot of growth over the last several months,” said John Potthoff, Ph.D., CEO at Elligo. “Both Dan’s and Michael’s experience and respective strengths will keep our team at the forefront of the effort to bring clinical research and clinical care together to improve research study participation and trial quality across the board.”

About Elligo
Elligo Health Research, an integrated research organization, expands access to clinical research by bringing together health care data, community physicians and their patients. Only Elligo’s Goes Direct® approach and IntElligo Research Stack™ clinical technology — a complete standards-based technology solution — deliver better patients and improved real-time data through Elligo’s network of Research Ready sites within its Communities of Research. Learn more at elligodirect.com.

Latest stories

Related stories

Why Custom Tin Containers Are Reshaping Medicine & Supplement Packaging

In an industry driven by both compliance and consumer...

Sarclisa by Sanofi has EC Approval to Treat Multiple Myeloma

In order to treat multiple myeloma in adults, Sarclisa...

US Levies 15% Tariff on EU for Pharmaceutical Products

The European Union is going to pay the US...

EU-US Trade Deal Taking Shape as Pharma Tariffs Materialize

Finally, the Trump administration’s much-animated tariffs on pharmaceutical imports...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back